NYSE - Delayed Quote USD

Elevance Health, Inc. (ELV)

403.81
+0.52
+(0.13%)
At close: May 19 at 4:00:01 PM EDT
409.00
+5.19
+(1.29%)
After hours: 8:00:00 PM EDT
Loading Chart for ELV
  • Previous Close 403.29
  • Open 405.27
  • Bid 388.00 x 800
  • Ask 402.97 x 1200
  • Day's Range 397.83 - 407.00
  • 52 Week Range 357.45 - 567.26
  • Volume 1,329,140
  • Avg. Volume 1,762,852
  • Market Cap (intraday) 91.235B
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) 15.72
  • EPS (TTM) 25.69
  • Earnings Date Jul 15, 2025 - Jul 21, 2025
  • Forward Dividend & Yield 6.84 (1.70%)
  • Ex-Dividend Date Jun 10, 2025
  • 1y Target Est 505.44

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

www.elevancehealth.com

104,200

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ELV

View More

Performance Overview: ELV

Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ELV
9.92%
S&P 500 (^GSPC)
1.39%

1-Year Return

ELV
25.21%
S&P 500 (^GSPC)
12.45%

3-Year Return

ELV
12.60%
S&P 500 (^GSPC)
52.88%

5-Year Return

ELV
52.92%
S&P 500 (^GSPC)
104.03%

Compare To: ELV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ELV

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    91.12B

  • Enterprise Value

    113.62B

  • Trailing P/E

    15.69

  • Forward P/E

    11.70

  • PEG Ratio (5yr expected)

    0.73

  • Price/Sales (ttm)

    0.51

  • Price/Book (mrq)

    2.14

  • Enterprise Value/Revenue

    0.62

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.23%

  • Return on Assets (ttm)

    4.93%

  • Return on Equity (ttm)

    14.18%

  • Revenue (ttm)

    183.12B

  • Net Income Avi to Common (ttm)

    5.92B

  • Diluted EPS (ttm)

    25.69

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    33.65B

  • Total Debt/Equity (mrq)

    70.40%

  • Levered Free Cash Flow (ttm)

    7.44B

Research Analysis: ELV

View More

Company Insights: ELV

Research Reports: ELV

View More

People Also Watch